Skip to main content
. 2017 Jan 31;7:41695. doi: 10.1038/srep41695

Table 2. Univariate survival analyses of HCC patients according to various clinicopathological variables.

Variable n 3-year CSS (%) 5-year CSS (%) Log rank χ2 test P
Years of diagnosis       124.997 P < 0.001
 1988–1994 557 29.7% 23.0%    
 1995–2001 2212 35.4% 27.8%    
 2002–2007 5852 45.8% 38.3%    
Sex       1.991 0.158
 Male 6341 41.8% 34.3%    
 Female 2280 42.9% 35.7%    
Age       309.794 P < 0.001
 <45 659 50.2% 43.9%    
 45–60 3520 49.1% 42.5%    
 61–75 3283 37.9% 29.5%    
 >75 1159 26.6% 17.7%    
Race       38.560 P < 0.001
 Caucasian 5425 42.1% 35.1%    
 African American 914 34.0% 26.0%    
 Others* 2282 45.3% 36.9%    
Pathological grading       327.616 P < 0.001
 High/Moderate 6564 45.6% 38.4%    
 Poor/undifferentiation 2057 28.0% 22.4%    
Stage       1440.866 P < 0.001
 Localized 5216 54.6% 45.9%    
 Regional 2471 27.2% 20.7%    
 Distant 934 10.1% 6.7%    
Tumor size (mm)       1019.417 P < 0.001
 <3 cm 1747 69.9% 62.2%    
 3–5 cm 2434 46.7% 38.5%    
 >5 cm 4440 28.3% 21.3%    
Marital Status       77.744 P < 0.001
 Married 5457 44.5% 36.9%    
 Never married 1399 40.6% 33.4%    
 Divorced/Separated 940 40.2% 33.5%    
 Widowed 825 20.2% 21.8%    

*Including other (American Indian/AK Native, Asian/Pacific Islander) and unknowns.